Nurix Therapeutics (NRIX) Tax Provisions (2019 - 2026)
Nurix Therapeutics (NRIX) posted quarterly Tax Provisions of -$271000.0 for Q2 2026, down 135.66% year-over-year from $760000.0 in Q2 2025, and down 135.66% quarter-over-quarter from $760000.0 in Q2 2025.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Tax Provisions (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has reported Tax Provisions for 6 consecutive years, with -$271000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Provisions fell 135.66% year-over-year to -$271000.0; the TTM figure through May 2026 stood at $489000.0 (down 42.47% YoY), while the FY2025 annual figure was $760000.0, up 181.48% from the prior year.
- Tax Provisions fell to -$271000.0 in Q2 2026 per NRIX's latest filing, from $760000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $760000.0 in Q2 2025 and bottomed at -$271000.0 in Q2 2026.
- Historically, Tax Provisions has averaged $126500.0 across 3 years, with a median of $86000.0 in 2024.
- Annual changes were most pronounced in 2025 — Tax Provisions surged 744.44% — and 2026, when it plunged 135.66%.
- Nurix Therapeutics' Tax Provisions stood at $8000.0 in 2024, then surged by 9400.0% to $760000.0 in 2025, then sank by 135.66% to -$271000.0 in 2026.
- Business Quant data shows NRIX's Tax Provisions at -$271000.0 in Q2 2026, $760000.0 in Q2 2025, and $8000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.41 Bn | - | -271,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -271,000.00 |
| May 31, 2025 | 760,000.00 |
| Nov 30, 2024 | 8,000.00 |
| Aug 31, 2024 | 82,000.00 |
| May 31, 2024 | 90,000.00 |
| Feb 29, 2024 | 90,000.00 |
| Nov 30, 2021 | 31,000.00 |
| Aug 31, 2021 | -123,000.00 |
| May 31, 2021 | 139,000.00 |
| Feb 28, 2021 | 71,000.00 |
| Nov 30, 2020 | 23,000.00 |
| May 31, 2020 | -20.59 Mn |
| Feb 29, 2020 | 11,000.00 |
| Nov 30, 2019 | 210,000.00 |
| Aug 31, 2019 | 10,000.00 |